Investigators at the University of Cape Town (UCT) are working with the South African National Blood Service (SANBS) and the Western Cape Blood Service (WCBS) to conduct the PROTECT-patient trial.
The HIATUS study, a research programme being launched by the Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa) at the University of Cape Town (UCT), will investigate the interaction between the COVID-19 pandemic and common endemic infectious diseases in the South African context.
The grant will enable CIDRI-Africa to further deepen our researcher community as public engagement champions, engage local communities and stakeholders, and raise awareness of research results.
TB: Scientists know a great deal, but there’s still more to learn
+27 (0)21 406 6797
Institute of Infectious Disease
and Molecular Medicine
University of Cape Town
Supported by the Wellcome Trust (203135/Z/16/Z)